To access this element change to forms mode OFF
Grant Award View - GA65996
Liver targeted Interleukin-22 for the treatment of non-alcoholic...
GA ID:
GA65996
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$622,168.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Liver targeted Interleukin-22 for the treatment of non-alcoholic steatohepatitis
Purpose:
1.2 million people were diagnosed with diabetes in 2016 in Australia and more than 70 percent of them have the associated disorder Non-Alcoholic Fatty Liver Disease (NAFLD). 30 percent of Australian adults have NAFLD, which makes it the most prevalent cause of serious liver injury in Australia. The discovery of anti-NAFLD effects of IL-22 provides a window into a range of totally new approaches to reverse lipid accumulation, inflammation and fibrosis with IL-22-targeted therapy.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1183713
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Queensland
Recipient ABN:
63 942 912 684
Grant Recipient Location
Suburb:
St Lucia
Town/City:
St Lucia
Postcode:
4072
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, QLD
Postcode:
Multiple
Country:
AUSTRALIA